JAC Cross-resistance patterns among clinical isolates of Klebsiella pneumoniae with decreased susceptibility to cefuroxime
|
|
- Felicity Todd
- 6 years ago
- Views:
Transcription
1 Journal of Antimicrobial Chemotherapy (2000) 46, JAC Cross-resistance patterns among clinical isolates of Klebsiella pneumoniae with decreased susceptibility to cefuroxime Helga Schumacher a *, Jens Scheibel b and Jens Kjølseth Møller a a Department of Clinical Microbiology, Aarhus University Hospital and b Department of Clinical Microbiology, The University Hospital in Copenhagen County, Denmark The frequency of decreased susceptibility to cefuroxime and quinolones and the correlation between these drug resistance traits was investigated in clinical isolates of Klebsiella pneumoniae from two Danish counties. Eighty-three randomly selected clinical isolates of K. pneumoniae with decreased susceptibility to cefuroxime were examined for cross-resistance patterns and the production of β-lactamases. The frequency of resistance to cefuroxime and ciprofloxacin has increased from <5% in 1990 to 15% and 7% in 1998, respectively. Two of the 83 isolates were multiply resistant and seemed to produce extended-spectrum β-lactamases. However, cross-resistance to ciprofloxacin and other classes of drug in 68% of the remaining isolates indicates that other resistance mechanisms, such as penetration barriers, had probably been selected in these Danish isolates. The susceptibility to ciprofloxacin decreased successively with decreasing susceptibility to cefuroxime for K. pneumoniae. This did not occur in cefuroxime-resistant Escherichia coli. Introduction Klebsiella pneumoniae isolates are generally susceptible to cefuroxime, since the SHV-1 β-lactamase produced by the majority of strains does not hydrolyse this cephalosporin. It is a matter of debate whether acquired resistance to one cephalosporin implies resistance to all cephalosporins among K. pneumoniae. 1 The fluoroquinolones seem to be an alternative for the treatment of serious infections caused by cefuroxime-resistant K. pneumoniae. A previous investigation of 20 cefuroxime-resistant K. pneumoniae showed that five isolates produced extended-spectrum β-lactamases (ESBLs), but all isolates had a 10-fold increase in ciprofloxacin MICs. 2 It is of clinical importance to note the possibility of cross-resistance to β-lactam antibiotics and quinolones. 3 Serious infections with K. pneumoniae are associated with a higher mortality rate than infections with other Enterobacteriaceae, so efficient initial antibiotic coverage is essential. 4 The aim of this study was to investigate the frequency of decreased susceptibility to cefuroxime and quinolones and the correlation between these drug resistance traits among clinical isolates of K. pneumoniae in two Danish counties. The results were compared with similar data for Escherichia coli. Eighty-three clinical isolates of K. pneumoniae with decreased susceptibility to cefuroxime were further examined for other cross-resistance patterns and production of ESBLs. Materials and methods Data from the Department of Clinical Microbiology, Aarhus University Hospital in Aarhus county (county A) and the Department of Clinical Microbiology, Herlev University Hospital in Copenhagen county (county B) were compared. Bacterial strains The frequency of resistance to cefuroxime and ciprofloxacin was investigated for isolates from two Danish counties. In county A, 83 isolates of K. pneumoniae with decreased susceptibility to cefuroxime were randomly selected in the periods 1 January to 1 August 1997 and 1 May to 23 July Repeat isolates (identical isolates from the same specimen within 3 weeks) were excluded. E. coli ATCC and other isolates with known MICs of cefuroxime and ciprofloxacin were included as controls for susceptibility testing and MIC determinations. E. coli *Corresponding author. Tel: ; Fax: ; helga.schumacher@inet.uni2.dk 2000 The British Society for Antimicrobial Chemotherapy 215
2 H. Schumacher et al. producing the β-lactamases TEM-1 and SHV-1, SHV-2, (supplied by A. Harris, Glaxo Wellcome, Greenford, UK), SHV-3 (supplied by D. Sirot, Université de Clermont- Ferrand, France), and SHV-4 and SHV-5 (supplied by T. Medeiros, Long Island, USA) were used as reference isolates for β-lactamase investigation. All bacteria were stored at 80 C. Antibiotics and discs Antibiotics were supplied by their respective manufacturers as standard powders. Discs prepared in-house contained gentamicin 20 g, cefuroxime 40 g, cefotaxime 25 g, ceftazidime 25 g, ciprofloxacin 2.5 g, chloramphenicol 50 g or tetracycline 20 g. Tablets from Rosco Neo Sensitabs (Taastrup, Denmark) contained cefuroxime 60 g, cefotaxime 30 g, ceftazidime 30 g or amoxycillin clavulanate 30 g/15 g. Etest strips containing cefuroxime, cefotaxime, ceftazidime, ciprofloxacin or ceftazidime clavulanate were from AB-Biodisk (Solna, Sweden). Media Nutrient beef broth, a basal culture medium (Statens Seruminstitut, Copenhagen, Denmark), contained 1000 ml water, 400 g beef infusion, 0.3 g glucose, 3.0 g sodium chloride, 2.0 g disodium hydrogen phosphate 12H 2 O and 10.0 g peptone in a volume of 7 ml; the ph was adjusted to ph 7.4. MacConkey agar (Statens Seruminstitut) contained 1000 ml water, 20.0 g peptone, 10.0 g lactose, 5.0 g sodium chloride, 106 ml ox bile, g neutral red, 9.0 g agar, ph 7.2; 23 g of this medium was used in 9 cm Petri dishes. Danish blood agar plates 5 were from Statens Seruminstitut. PDM agar plates, containing 31.5 g/l PDM antibiotic sensitivity medium (obtained as a powder from AB-Biodisk), were produced at Herlev University Hospital, Herlev, Denmark. Frequency of resistance ( ) Data on the frequency of resistance to cefuroxime and ciprofloxacin in county A, retrieved from MADS, a computerized microbiology reporting system, 6 were compared with similar data from county B, obtained from the ADBact microbiological reporting system (Autonic AB; RAM- STA, Skøldinge, Sweden). Cross-resistance Cross-resistance to cefuroxime and ciprofloxacin was investigated for all K. pneumoniae and E. coli isolates from 1992 to 1998 in county B by preparing frequency histograms of ciprofloxacin zone diameters for cefuroximesusceptible, -intermediate and -resistant isolates. Similar histograms of cefuroxime zones were made for ciprofloxacin-susceptible and -resistant isolates. Repeat isolates (identical isolates obtained from the same patient within 3 weeks) were excluded. Identification of bacteria The 83 isolates were identified with the API 20 E Bio typing system (biomérieux, Mary l Etoile, France). Susceptibility tests The methods used for routine susceptibility testing differed between counties A and B. County A. Here the susceptibility to cefuroxime, ceftazidime, cefotaxime, gentamicin, chloramphenicol, tetracycline, ciprofloxacin and nalidixic acid was determined with a prediffusion test, 7,8 the routine susceptibility test method in that county. In this method, there is a period of prediffusion, in which antibiotic-containing discs are placed on the surface of the agar and kept at 5 C for 18 h before inoculation of bacteria. An antibiotic gradient is formed in the agar before growth of the bacteria begins; the influence of growth rate and inoculum on zone formation is hence diminished. The effect of introducing a prediffusion time on the dynamics of zone formation can be expressed mathematically; the amount of antibiotic (m ) that is just capable of inhibiting microbial growth under certain test conditions is called the critical concentration, and can be expressed by the general formula ln m ln m 0 (x 2 /(4D t 0 )) where m 0 is the concentration of antibiotic applied to the agar surface, x is the distance between the reservoir and the edge of the zone of inhibition, D is the diffusion coefficient for the antibiotic under the test conditions and t 0 is the time at which the position of the zone of inhibition is determined. t 0 is determined by the size of inoculum and the growth rate of the organism. When a prediffusion period is introduced, t 0 is greater and the antibiotic concentration gradient determining the zone of inhibition is formed before bacteria are added, so the influence of growth rate and inoculum on formation of the zone is reduced similarly. 8 County B. In county B, the routine susceptibility test method is the Biodisk system (AB-Biodisk) on PDM agar plates. This method was used to determine susceptibility to cefuroxime and ciprofloxacin. Detection of β-lactamases β-lactamases were detected using a tablet approximation test. 7 Neo Sensitab tablets (Rosco) containing cefuroxime, ceftriaxone or ceftazidime were placed 1.5 and 2.0 cm from the edge of a tablet containing amoxycillin clavulanate. 216
3 Cross-resistance in Klebsiella pneumoniae ESBL production was inferred when the inhibition zone for the test antibiotics was extended by 3 mm towards the tablet containing amoxycillin clavulanate. For resistant isolates, with small zone diameters, the extension of the zones was measured using tablets placed 1.5 cm apart; larger zone diameter extensions were clearer when discs were 2 cm apart. For ESBL-negative strains, no extension was seen at either of these distances. 7 Isolates with decreased susceptibility to ceftazidime or cefotaxime were also tested for production of ESBLs with the ESBL Etest, as described by the manufacturer. Determination of MIC Cefuroxime, cefotaxime, ceftazidime and ciprofloxacin MICs were determined by the Etest as described by the manufacturer. An inoculum resulting in semiconfluent growth was used on all plates; plates were incubated for 18 h at 35 C before zone diameters and MICs were determined. Breakpoints for susceptibility, decreased susceptibility and resistance are shown in Table I. The breakpoints for the Biodisk system used in county A were recommended by the manufacturer of PDM sensitivity test medium (AB-Biodisk). In county B, breakpoints were calculated according to regression analysis and frequency histograms of MICs (agar dilution method) and zone diameters (prediffusion method on Danish blood agar) for a variety of clinical isolates. Characterization of β-lactamases The crude enzyme preparations used for characterizing β-lactamases were prepared as follows. Danish blood agar plates were inoculated with bacteria and incubated overnight. The bacteria were harvested and suspended in 5 ml phosphate buffer, ph 6.0. Polymyxin was added to a concentration of 0.1 mg/l to cause partial disintegration of the Table I. MIC breakpoints for the prediffusion method and the AB-Biodisk system MICs (mg/l) Antibiotic susceptible resistant Gentamicin Cefuroxime 2 a / 4 b 16 Ceftazidime 2 16 Cefotaxime 2 16 Nalidixic acid 4 16 Ciprofloxacin a /<1 b 4 a / 8 b Chloramphenicol 2 16 Tetracycline 2 16 a Prediffusion method. b AB-Biodisk methods. outer membrane 9 before application of 10 freeze thaw cycles. After centrifugation at 13000g for 30 min, the crude enzymes were stored at 20 C. Isoelectric focusing was performed using the Ready Gel System (Bio-Rad) as described by the manufacturer. This method is particularly suited for screening, but not for determining precise pi values. Isoelectric focusing was repeated for enzymes with bands different from that of SHV-1 (pi 7.6). Results Frequency of resistance in general in In county A, the frequency of decreased susceptibility to cefuroxime and ciprofloxacin among K. pneumoniae isolates was 15% and 7%, respectively (n 1267), while that in county B was 14% and 8.7%, respectively (n 219). About 70% of the ciprofloxacin-resistant isolates in county A were also resistant to cefuroxime, while all ciprofloxacin-resistant isolates in county B were also resistant to cefuroxime. Figure 1 shows the distribution of ciprofloxacin zone diameters among cefuroxime-susceptible, -intermediate and -resistant isolates of K. pneumoniae. The median ciprofloxacin zone diameter was 31 and 26 mm among cefuroxime-susceptible and -resistant isolates, respectively. Figure 1 also shows the frequency histogram of cefuroxime zone diameters for ciprofloxacin-resistant isolates, where all ciprofloxacin-resistant isolates were cross-resistant to cefuroxime. The distribution of ciprofloxacin zone diameters among cefuroxime-susceptible and -resistant E. coli is shown in Figure 2. Here the median ciprofloxacin zone diameter for cefuroxime-susceptible isolates was similar to that for cefuroxime-resistant isolates. Other resistance patterns in county A Of 1267 isolates from 853 patients (86% of the isolates were from urinary tract specimens), 83 K. pneumoniae isolates with decreased susceptibility to cefuroxime were randomly selected for further investigation. Of these 83 isolates, only 75 had decreased susceptibility to cefuroxime when retested. The frequency of decreased susceptibility to cefotaxime, ceftazidime, gentamicin, tetracycline, nalidixic acid and ciprofloxacin for the 75 isolates is shown in Table II together with similar frequencies for the same antibiotics among 356 cefuroxime-susceptible blood culture isolates from county A. All isolates with decreased susceptibility to ciprofloxacin were resistant to nalidixic acid. Six isolates were susceptible to ciprofloxacin but resistant to nalidixic acid. Concomitant decreased susceptibility to cefuroxime and ciprofloxacin was seen in 51 of the 75 cefuroximeresistant isolates, and further resistance to nalidixic acid, chloramphenicol and tetracycline was seen in 44 of the 75 isolates (Table II). Ten isolates had slightly decreased 217
4 H. Schumacher et al. inhibition zones for ceftazidime but MICs were 2 mg/l. Two isolates were highly resistant to cephalosporins; one of these was resistant to all antibiotics except the quinolones and the second was susceptible only to gentamicin and quinolones. Other resistance patterns were less prevalent. MIC determinations According to MICs, 69 and 36 of the 83 isolates showed decreased susceptibility to both cefuroxime and ciprofloxacin, respectively. Two isolates were resistant to cefotaxime and ceftazidime. The remaining isolates all had cefotaxime and ceftazidime MICs of 2 mg/l. β-lactamase production One of the two multiply resistant isolates was positive both in the disc approximation test and in the ESBL Etest. For all other cefuroxime-resistant K. pneumoniae there was no indication of production of ESBLs according to MICs, disc approximation tests and ESBL Etests. Isoelectric focusing of crude enzyme preparations from the 83 isolates showed Figure 1. Cross-resistance among Klebsiella pneumoniae visualized using frequency histograms of ciprofloxacin zone diameters among isolates that were (a) susceptible, (b) intermediate and (c) resistant to cefuroxime; (d) cefuroxime zone diameters among ciprofloxacinresistant isolates. The median is marked with a line on the x-axis. 218
5 Cross-resistance in Klebsiella pneumoniae Figure 2. Frequency histograms of ciprofloxacin zone diameters among (a) cefuroxime-susceptible and (b) cefuroxime-resistant Escherichia coli. The median is marked with a line on the x-axis. Table II. Cross-resistance between different antibiotics among isolates of Klebsiella pneumoniae obtained from Aarhus county which were either fully susceptible or showed decreased susceptibility to cefuroxime Isolates with decreased susceptibility Isolates susceptible to to cefuroxime (1997 8), from cefuroxime (1992 8), Antibiotic various sources (n 75) from blood (n 356) Ceftazidime 13 (17%) 1 ( 1%) Cefotaxime 3 (4%) 0 (0%) Ciprofloxacin 51 (68%) 20 (5%) Nalidixic acid 49 (65%) ND Chloramphenicol 68 (91%) 28 (7%) Tetracycline 67 (89%) 36 (9%) Gentamicin 2 (3%) 1 ( 1%) ND, not determined. that 81 isolates had bands similar to those from the reference isolate producing SHV-1, while the two multiply resistant isolates produced enzymes with different bands indicating production of other enzymes. The 10 isolates with slightly decreased ceftazidime susceptibility were not ESBL producers according to MICs, disc approximation test, ESBL Etests and isoelectric focusing of the β-lactamases. Discussion In 1990, 5% of K. pneumoniae from Danish intensive care units showed decreased susceptibility to cefuroxime and ciprofloxacin. 10 We have shown that the frequency of decreased susceptibility to cefuroxime has increased to about 15% in both counties while that to ciprofloxacin has increased to 7% and 9% in counties A and B, respectively, with a considerable degree of cross-resistance to both antibiotics. In county B the susceptibility to ciprofloxacin is not routinely determined for isolates of K. pneumoniae; it is usually only determined if a strain is also resistant to other antibiotics. This may result in the slightly higher frequency of ciprofloxacin resistance. The cross-resistance between cefuroxime and ciprofloxacin seen in county A (Table II) was illustrated differently in county B where the median ciprofloxacin zone diameter increased successively with increasing cefur- 219
6 H. Schumacher et al. oxime zone diameters (Figure 1). Such a gradual shift of decreased susceptibility to ciprofloxacin could not be demonstrated for cefuroxime-resistant isolates of E. coli (Figure 2), perhaps because there are other resistance mechanisms in E. coli, such as a higher level of chromosomal mediated β-lactamase production as shown previously. 11 Mutations in the gyrase and topoisomerase IV genes are believed to be the primary cause of quinolone resistance. 12 Less frequent mechanisms are multiple antibiotic resistance genes (mar genes), 13 active efflux 14 and changes in outer membrane proteins. 15,16 They generally result in a low level of quinolone resistance and cross-resistance to chloramphenicol, tetracyclines and β-lactams, 3,13 16 as was found in this study (Table I). The low-level resistance may be shifted to higher levels and result in failure of therapy. 17 However, it has been shown previously that threetimes-daily dosing of ciprofloxacin (with 400 mg) improved treatment of K. pneumoniae with an MIC of 0.5 mg/l. 18 Decreased susceptibility to ciprofloxacin seems difficult to detect by routine susceptibility tests used in Denmark (unpublished data). Similar problems with Enterobacter cloacae and Salmonella spp. have been reported Recently, it was shown that salmonellae with reduced ciprofloxacin susceptibility were uniformly resistant to nalidixic acid. 22 This indicates that resistance to a quinolone with lower activity is likely to be associated with decreased susceptibility or resistance to the newer and more active fluoroquinolones. Our study indicates that K. pneumoniae with a low level of resistance to ciprofloxacin may also be resistant to nalidixic acid. It will be interesting to see if this applies to other Enterobacteriaceae as well. In Denmark, only two reports of ESBL-producing K. pneumoniae have been published. 2,23 The SHV-1 enzymes usually produced by K. pneumoniae are less able to hydrolyse cephalosporins than other SHV enzymes (ESBLs). In this study, only two isolates seemed to produce enzymes other than SHV-1, presumably ESBLs. They were easily detected using an ordinary susceptibility test. The third-generation cephalosporins may still be useful for treating infections caused by K. pneumoniae with decreased susceptibility to ciprofloxacin, since they seem less affected by a penetration barrier than cefuroxime 24,25 and the use of higher doses and longer duration of therapy may be of benefit. 26 In conclusion, considerable cross-resistance was seen between cefuroxime and ciprofloxacin among the K. pneumoniae isolates tested, while multiple resistance and production of ESBLs was only detected in a few isolates. Susceptibility to ciprofloxacin decreased successively with decreasing susceptibility to cefuroxime, as shown by the frequency histograms, which are useful for detecting and comparing combinations of resistance traits. Guidelines for detection of decreased susceptibility and sufficient antibiotic therapy may need to be adjusted when a stepwise shift in resistance is seen. Acknowledgements We thank Steen Hoffmann for helpful discussions, and Sami Majeed, Marianne Bøgild and Kirsten Jensen for valuable technical assistance. References 1. Rice, L. B., Yao, J. D., Klimm, K., Eliopoulos, G. M. & Moellering, R. C. (1991). Efficacy of different β-lactams against an extendedspectrum β-lactamase-producing Klebsiella pneumoniae strain in the rat intra-abdominal abscess model. Antimicrobial Agents and Chemotherapy 35, Schumacher, H., Skibsted U., Hansen, D. S. & Scheibel, J. (1997). Cefuroxime resistance in Klebsiella pneumoniae: susceptibility to cefotaxime and ceftazidime despite production of ESBLs. Acta Pathologica Microbiologica et Immunologica Scandinavica 105, Sanders, C. C., Sanders, W. E., Goering, R. V. & Werner, V. (1984). Selection of multiple antibiotic resistance by quinolones, β-lactams, and aminoglycosides with special reference to crossresistance between unrelated drug classes. Antimicrobial Agents and Chemotherapy 26, Pedersen, G., Schønheyder, H. C. & Sørensen, H. T. (1997). Antibiotic therapy and outcome of monomicrobial gram-negative bacteraemia: A 3-year population-based study. Scandinavian Journal of Infectious Diseases 29, Jensen, K. T., Schønheyder, H., Pers, C. & Thomsen, V. F. (1992). In vitro activity of teicoplanin and vancomycin against grampositive bacteria from human clinical and veterinary sources. Acta Pathologica Microbiologica et Immunologica Scandinavica 100, Møller, J. K. (1984). A microcomputer-assisted bacteriology reporting and information system. Acta Pathologica Microbiologica et Immunologica Scandinavica B 92, Schumacher, H., Bengtsson, B., Bjerregaard-Andersen, H. & Jensen, T. G. (1998). Detection of extended spectrum β-lactamases. Acta Pathologica Microbiologica et Immunologica Scandinavica 106, Thomsen, V. F. (1962). Correlation of the plate-dilution method to the agar diffusion method (disc- and tablet-method) with a special view to the importance of pre-diffusion. Acta Pathologica Microbiologica et Immunologica Scandinavica 54, Vaara, M. & Vaara, T. (1981). Outer membrane permeability barrier disruption by polymyxin in polymyxin-susceptible and -resistant Salmonella typhimurium. Antimicrobial Agents and Chemotherapy 19, Schumacher, H., Bremmelgaard, A., Holten-Andersen, W. R., Rasmussen, H. & Højbjerg, T. (1994). Resistant Gram-negative bacteria at seven intensive care units in Denmark. Ugeskrift for Læger 156, Schumacher, H., Skibsted, U., Skov, R. & Scheibel, J. (1996). Cefuroxime resistance in Escherichia coli. Resistance mechanisms and prevalence. Acta Pathologica Microbiologica et Immunologica Scandinavica 104, Drlica, K. & Zhao, X. (1997). DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiology and Molecular Biology Reviews 61,
7 Cross-resistance in Klebsiella pneumoniae 13. Alekshun, M. N. & Levy, S. B. (1997). Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon. Antimicrobial Agents and Chemotherapy 41, Levy, S. B. (1992). Active efflux mechanisms for antimicrobial resistance. Antimicrobial Agents and Chemotherapy 36, Chen, H. Y. & Livermore, D. M. (1993). Activity of cefepime and other β-lactam antibiotics against permeability mutants of Escherichia coli and Klebsiella pneumoniae. Journal of Antimicrobial Chemotherapy 32, Suppl. B, Gutmann, L., Williamson, N. R., Moreau, N., Kitzis, M. D., Collatz, E., Acar, J. F. et al. (1985). Cross-resistance to nalidixic acid, trimethoprim, and chloramphenicol associated with alterations in outer membrane proteins of Klebsiella, Enterobacter, and Serratia. Journal of Infectious Diseases 151, Martínez, J. L., Alonso, A., Gómez-Gómez, J. M. & Baquero F. (1998). Quinolone resistance by mutations in chromosomal gyrase genes. Just the tip of the iceberg? Journal of Antimicrobial Chemotherapy 42, Bauernfeind, A. (1993). Questioning dosing regimens for ciprofloxacin. Journal of Antimicrobial Chemotherapy 31, Deguchi, T., Yasuda, M., Nakano, M., Ozeki, S., Kanematsu, E. & Nishino, Y. et al. (1997). Detection of mutations in gyra and parc genes in quinolone-resistant clinical isolates of Enterobacter cloacae. Journal of Antimicrobial Chemotherapy 40, Piddock, L. J., Ricci, V., McLaren, I. & Griggs, D. J. (1998). Role of mutation in the gyra and parc genes of nalidixic-acid-resistant salmonella serotypes isolated from animals in the United Kingdom. Journal of Antimicrobial Chemotherapy 41, Threlfall, E. J., Ward, L. R. & Rowe, B. (1999). Resistance to ciprofloxacin in non-typhoidal salmonellas from humans in England and Wales the current situation. Clinical Microbiology and Infection 5, Hakanen, A., Kotilainen, P., Jalava, J., Siitonen, A. & Huovinen, P. (1999). Detection of decreased fluoroquinolone susceptibility in salmonellas and validation of nalidixic acid screening test. Journal of Clinical Microbiology 37, Hansen, D. S., Sirot, D. & Kolmos, H. J. (1998). Extended spectrum beta-lactamases in Danish Klebsiella isolates. Ugeskrift for Læger 160, Nikaido, H. (1988). Bacterial resistance to antibiotics as a function of outer membrane permeability. Journal of Antimicrobial Chemotherapy 22, Suppl. A, Yoshimura, F. & Nikaido, H. (1985). Diffusion of β-lactam antibiotics through the porin channels of Escherichia coli K-12. Antimicrobial Agents and Chemotherapy 27, Thauvin-Eliopoulos, C., Tripodi, M. F., Moellering, R. C. & Eliopoulos, G. M. (1997). Efficacies of piperacillin tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended-spectrum β-lactamase producing strain of Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy 41, Received 25 June 1999; returned 2 December 1999; revised 11 January 2000; accepted 21 March
8
ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat
ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat Hicham Ezzat Professor of Microbiology and Immunology Cairo University Introduction 1 Since the 1980s there have been dramatic
More informationMechanism of antibiotic resistance
Mechanism of antibiotic resistance Dr.Siriwoot Sookkhee Ph.D (Biopharmaceutics) Department of Microbiology Faculty of Medicine, Chiang Mai University Antibiotic resistance Cross-resistance : resistance
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The
More informationSuggestions for appropriate agents to include in routine antimicrobial susceptibility testing
Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory
More information2015 Antimicrobial Susceptibility Report
Gram negative Sepsis Outcome Programme (GNSOP) 2015 Antimicrobial Susceptibility Report Prepared by A/Professor Thomas Gottlieb Concord Hospital Sydney Jan Bell The University of Adelaide Adelaide On behalf
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01
More informationEXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING
EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING CHN61: EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING 1.1 Introduction A common mechanism of bacterial resistance to beta-lactam antibiotics is the production
More informationHelen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory
METHODS USED IN NEW ZEALAND DIAGNOSTIC LABORATORIES TO IDENTIFY AND REPORT EXTENDED-SPECTRUM β-lactamase- PRODUCING ENTEROBACTERIACEAE by Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory
More informationOriginal Article. Ratri Hortiwakul, M.Sc.*, Pantip Chayakul, M.D.*, Natnicha Ingviya, B.Sc.**
Original Article In Vitro Activity of Cefminox and Other β-lactam Antibiotics Against Clinical Isolates of Extended- Spectrum-β-lactamase-Producing Klebsiella pneumoniae and Escherichia coli Ratri Hortiwakul,
More informationTHE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS
THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS Stefanie Desmet University Hospitals Leuven Laboratory medicine microbiology stefanie.desmet@uzleuven.be
More informationa. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.
AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony
More informationWhat s new in EUCAST methods?
What s new in EUCAST methods? Derek Brown EUCAST Scientific Secretary Interactive question 1 MIC determination MH-F broth for broth microdilution testing of fastidious microorganisms Gradient MIC tests
More informationMili Rani Saha and Sanya Tahmina Jhora. Department of Microbiology, Sir Salimullah Medical College, Mitford, Dhaka, Bangladesh
Detection of extended spectrum beta-lactamase producing Gram-negative organisms: hospital prevalence and comparison of double disc synergy and E-test methods Mili Rani Saha and Sanya Tahmina Jhora Original
More informationComparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria
Comparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria Juhee Ahn Department of Medical Biomaterials Engineering Kangwon National University October 23, 27 Antibiotic Development
More informationJanuary 2014 Vol. 34 No. 1
January 2014 Vol. 34 No. 1. and Minimal Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) roth dilution: cation-adjusted Mueller-Hinton
More informationHelp with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST
Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to
More informationStreptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance
Streptococcus pneumoniae Oxacillin µg as screen for beta-lactam resistance Version 6. June Streptococcus pneumoniae and zone diameter correlates The following histograms present inhibition zone diameter
More informationESBL- and carbapenemase-producing microorganisms; state of the art. Laurent POIREL
ESBL- and carbapenemase-producing microorganisms; state of the art Laurent POIREL Medical and Molecular Microbiology Unit Dept of Medicine University of Fribourg Switzerland INSERM U914 «Emerging Resistance
More informationEUCAST Subcommitee for Detection of Resistance Mechanisms (ESDReM)
EUCAST Subcommitee for Detection of Resistance Mechanisms (ESDReM) Christian G. Giske, MD/PhD Chairman of ESDReM Karolinska University Hospital and EUCAST ECCMID, 22 maj 2013 The background Guidance on
More informationAPPENDIX III - DOUBLE DISK TEST FOR ESBL
Policy # MI\ANTI\04\03\v03 Page 1 of 5 Section: Antimicrobial Susceptibility Testing Manual Subject Title: Appendix III - Double Disk Test for ESBL Issued by: LABORATORY MANAGER Original Date: January
More informationRoutine internal quality control as recommended by EUCAST Version 3.1, valid from
Routine internal quality control as recommended by EUCAST Version.1, valid from 01-01-01 Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus
More informationPROTOCOL for serotyping and antimicrobial susceptibility testing of Salmonella test strains
PROTOCOL for serotyping and antimicrobial susceptibility testing of Salmonella test strains 1 INTRODUCTION... 1 2 OBJECTIVES... 2 3 OUTLINE OF THE EQAS 2017... 2 3.1 Shipping, receipt and storage of strains...
More informationجداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی
جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی ویرایش دوم بر اساس ed., 2017 CLSI M100 27 th تابستان ۶۹۳۱ تهیه
More informationPrevalence of Extended-spectrum β-lactamase Producing Enterobacteriaceae Strains in Latvia
Prevalence of Extended-spectrum β-lactamase Producing Enterobacteriaceae Strains in Latvia Ruta Paberza 1, Solvita Selderiņa 1, Sandra Leja 1, Jelena Storoženko 1, Lilija Lužbinska 1, Aija Žileviča 2*
More informationEUCAST recommended strains for internal quality control
EUCAST recommended strains for internal quality control Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus influenzae ATCC 59 ATCC
More informationConsequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered
Antimicrobial Resistance Consequences of Antimicrobial Resistant Bacteria Change in the approach to the administration of empiric antimicrobial therapy Increased number of hospitalizations Increased length
More informationThe impact of antimicrobial resistance on enteric infections in Vietnam Dr Stephen Baker
The impact of antimicrobial resistance on enteric infections in Vietnam Dr Stephen Baker sbaker@oucru.org Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam Outline The impact of antimicrobial
More informationMID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance
Antimicrobial Resistance Molecular Genetics of Antimicrobial Resistance Micro evolutionary change - point mutations Beta-lactamase mutation extends spectrum of the enzyme rpob gene (RNA polymerase) mutation
More informationIntrinsic, implied and default resistance
Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been
More informationAntimicrobial Resistance
Antimicrobial Resistance Consequences of Antimicrobial Resistant Bacteria Change in the approach to the administration of empiric antimicrobial therapy Increased number of hospitalizations Increased length
More informationAntimicrobial Resistance Acquisition of Foreign DNA
Antimicrobial Resistance Acquisition of Foreign DNA Levy, Scientific American Horizontal gene transfer is common, even between Gram positive and negative bacteria Plasmid - transfer of single or multiple
More informationChemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance
Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance evolution of antimicrobial resistance Mechanism of bacterial genetic variability Point mutations may occur in a nucleotide base pair,
More informationAntimicrobial Susceptibility Testing: The Basics
Antimicrobial Susceptibility Testing: The Basics Susan E. Sharp, Ph.D., DABMM, FAAM Director, Airport Way Regional Laboratory Director, Regional Microbiology and Molecular Infectious Diseases Laboratories
More informationPrevalence of Ciprofloxacin Resistance Among Gram-Negative Bacilli at a Specialist Hospital in Saudi Arabia
Bangladesh Journal of Medical Science Vol. 11 No. 04 Oct 12 Original article Prevalence of Ciprofloxacin Resistance Among Gram-Negative Bacilli at a Specialist Hospital in Saudi Arabia Ahmad S Abstract:
More informationChristiane Gaudreau* and Huguette Gilbert
Journal of Antimicrobial Chemotherapy (1997) 39, 707 712 JAC Comparison of disc diffusion and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni subsp. jejuni and Campylobacter
More informationThe Basics: Using CLSI Antimicrobial Susceptibility Testing Standards
The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards Janet A. Hindler, MCLS, MT(ASCP) UCLA Health System Los Angeles, California, USA jhindler@ucla.edu 1 Learning Objectives Describe information
More informationPrevalence of Extended Spectrum Beta- Lactamase Producers among Various Clinical Samples in a Tertiary Care Hospital: Kurnool District, India
International Journal of Current Microbiology and Applied Sciences ISSN: 319-77 Volume Number (17) pp. 57-3 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/1.5/ijcmas.17..31
More informationPDF hosted at the Radboud Repository of the Radboud University Nijmegen
PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/26062
More informationGeNei TM. Antibiotic Sensitivity. Teaching Kit Manual KT Revision No.: Bangalore Genei, 2007 Bangalore Genei, 2007
GeNei Bacterial Antibiotic Sensitivity Teaching Kit Manual Cat No. New Cat No. KT68 106333 Revision No.: 00180705 CONTENTS Page No. Objective 3 Principle 3 Kit Description 4 Materials Provided 5 Procedure
More informationESCMID Online Lecture Library. by author
Expert rules in susceptibility testing EUCAST-ESGARS-EPASG Educational Workshop Linz, 16 19 September, 2014 Dr. Rafael Cantón Hospital Universitario Ramón y Cajal SERVICIO DE MICROBIOLOGÍA Y PARASITOLOGÍA
More informationPrevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 4 Number 9 (2015) pp. 952-956 http://www.ijcmas.com Original Research Article Prevalence of Metallo-Beta-Lactamase
More informationAntimicrobials & Resistance
Antimicrobials & Resistance History 1908, Paul Ehrlich - Arsenic compound Arsphenamine 1929, Alexander Fleming - Discovery of Penicillin 1935, Gerhard Domag - Discovery of the red dye Prontosil (sulfonamide)
More informationCompliance of manufacturers of AST materials and devices with EUCAST guidelines
Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The
More informationAntibiotics: mode of action and mechanisms of resistance. Slides made by Special consultant Henrik Hasman Statens Serum Institut
Antibiotics: mode of action and mechanisms of resistance. Slides made by Special consultant Henrik Hasman Statens Serum Institut This presentation Definitions needed to discuss antimicrobial resistance
More informationSelective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016
Selective toxicity Antimicrobial Drugs Chapter 20 BIO 220 Drugs must work inside the host and harm the infective pathogens, but not the host Antibiotics are compounds produced by fungi or bacteria that
More informationBrief reports. Heat stability of the antimicrobial activity of sixty-two antibacterial agents
Journal of Antimicrobial Chemotherapy (5) 35, -5 Brief reports Heat stability of the antimicrobial activity of sixty-two antibacterial agents Walter H. Traub and Birgit Leonhard Institut fur Medizinische
More informationQuality assurance of antimicrobial susceptibility testing
Quality assurance of antimicrobial susceptibility testing Derek Brown Routine quality control Repeated testing of controls in parallel with tests to ensure that the test system is performing reproducibly
More informationAntimicrobial Pharmacodynamics
Antimicrobial Pharmacodynamics November 28, 2007 George P. Allen, Pharm.D. Assistant Professor, Pharmacy Practice OSU College of Pharmacy at OHSU Objectives Become familiar with PD parameters what they
More informationEvaluation of a new cefepime clavulanate ESBL Etest to detect extended-spectrum b-lactamases in an Enterobacteriaceae strain collection
Journal of Antimicrobial Chemotherapy (2004) 54, 134 138 DOI: 10.1093/jac/dkh274 Advance Access publication 18 May 2004 Evaluation of a new cefepime clavulanate ESBL Etest to detect extended-spectrum b-lactamases
More information2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine
2012 ANTIBIOGRAM Central Zone Former DTHR Sites Department of Pathology and Laboratory Medicine Medically Relevant Pathogens Based on Gram Morphology Gram-negative Bacilli Lactose Fermenters Non-lactose
More informationEUCAST-and CLSI potency NEO-SENSITABS
EUCASTand CLSI potency NEOSENSITABS Neo Sensitabs Page 1 / 6 Document: 6.2.0 Fastidious organisms EUCAST Interpretation zones and MIC breakpoints according to recommendations by the "Comité de l'antibiogramme
More informationEvaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals
J Vet Diagn Invest :164 168 (1998) Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals Susannah K. Hubert, Phouc Dinh Nguyen, Robert D. Walker Abstract.
More informationJAC Bactericidal index: a new way to assess quinolone bactericidal activity in vitro
Journal of Antimicrobial Chemotherapy (1997) 39, 713 717 JAC Bactericidal index: a new way to assess quinolone bactericidal activity in vitro Ian Morrissey* Department of Biosciences, Division of Biochemistry
More informationQ1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants.
Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants. C. difficile rarely causes problems, either in healthy adults or in infants.
More informationFlorida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC
Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC 11/20/2014 1 To describe carbapenem-resistant Enterobacteriaceae. To identify laboratory detection standards for carbapenem-resistant
More informationVersion 1.01 (01/10/2016)
CHN58: ANTIMICROBIAL SUSCEPTIBILITY TESTING (CLSI) 1.0 PURPOSE / INTRODUCTION: 1.1 Introduction Antimicrobial susceptibility tests are performed in order to determine whether a pathogen is likely to be
More informationCompliance of manufacturers of AST materials and devices with EUCAST guidelines
Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The
More informationOriginal Article. Suthan Srisangkaew, M.D. Malai Vorachit, D.Sc.
Original Article Vol. 21 No.1 The optimum agent for ESBL screening and confirmatory tests:- Srisangkaew S & Vorachit M. 1 The Optimum Agent for Screening and Confirmatory Tests for Extended-Spectrum Beta-Lactamases
More informationScottish Medicines Consortium
Scottish Medicines Consortium tigecycline 50mg vial of powder for intravenous infusion (Tygacil ) (277/06) Wyeth 9 June 2006 The Scottish Medicines Consortium (SMC) has completed its assessment of the
More informationThe β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018
The β- Lactam Antibiotics Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018 Penicillins. Cephalosporins. Carbapenems. Monobactams. The β- Lactam Antibiotics 2 3 How
More informationESCMID Online Lecture Library. by author
Quality Assurance of antimicrobial susceptibility testing Derek Brown EUCAST Scientific Secretary ESCMID Postgraduate Education Course, Linz, 17 September 2014 Quality Assurance The total process by which
More informationMichael Hombach*, Guido V. Bloemberg and Erik C. Böttger
J Antimicrob Chemother 2012; 67: 622 632 doi:10.1093/jac/dkr524 Advance Access publication 13 December 2011 Effects of clinical breakpoint changes in CLSI guidelines 2010/2011 and EUCAST guidelines 2011
More informationApproach to pediatric Antibiotics
Approach to pediatric Antibiotics Gassem Gohal FAAP FRCPC Assistant professor of Pediatrics objectives To be familiar with common pediatric antibiotics o Classification o Action o Adverse effect To discus
More informationAntimicrobial Resistance
Antimicrobial Resistance Consequences of Antimicrobial Resistant Bacteria Change in the approach to the administration of Change in the approach to the administration of empiric antimicrobial therapy Increased
More information2016 Antibiotic Susceptibility Report
Fairview Northland Medical Center and Elk River, Milaca, Princeton and Zimmerman Clinics 2016 Antibiotic Susceptibility Report GRAM-NEGATIVE ORGANISMS 2016 Gram-Negative Non-Urine The number of isolates
More informationSepsis is the most common cause of death in
ADDRESSING ANTIMICROBIAL RESISTANCE IN THE INTENSIVE CARE UNIT * John P. Quinn, MD ABSTRACT Two of the more common strategies for optimizing antimicrobial therapy in the intensive care unit (ICU) are antibiotic
More informationMultidrug-Resistant Salmonella enterica in the Democratic Republic of the Congo (DRC)
Multidrug-Resistant Salmonella enterica in the Democratic Republic of the Congo (DRC) Octavie Lunguya 1, Veerle Lejon 2, Sophie Bertrand 3, Raymond Vanhoof 3, Jan Verhaegen 4, Anthony M. Smith 5, Benedikt
More informationJanuary 2014 Vol. 34 No. 1
January 2014 Vol. 34 No. 1. and Minimum Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) Broth dilution: cation-adjusted Mueller-Hinton
More informationInteractive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe
Interactive session: adapting to antibiogram Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe Case 1 63 y old woman Dx: urosepsis? After 2 d: intermediate result: Gram-negative bacilli Empiric antibiotic
More informationOccurrence of Extended-Spectrum Beta-Lactamases Among Blood Culture Isolates of Gram-Negative Bacteria
Original Article Vol. 21 No. 2 ESBL producers among blood culture isolates:- Kapoor L, Deb M. 53 Occurrence of Extended-Spectrum Beta-Lactamases Among Blood Culture Isolates of Gram-Negative Bacteria Lata
More information2015 Antibiotic Susceptibility Report
Citrobacter freundii Enterobacter aerogenes Enterobacter cloacae Escherichia coli Haemophilus influenzenza Klebsiella oxytoca Klebsiella pneumoniae Proteus mirabilis Pseudomonas aeruginosa Serratia marcescens
More informationAntimicrobial susceptibility
Antimicrobial susceptibility PATTERNS Microbiology Department Canterbury ealth Laboratories and Clinical Pharmacology Department Canterbury District ealth Board March 2011 Contents Preface... Page 1 ANTIMICROBIAL
More informationGENERAL NOTES: 2016 site of infection type of organism location of the patient
GENERAL NOTES: This is a summary of the antibiotic sensitivity profile of clinical isolates recovered at AIIMS Bhopal Hospital during the year 2016. However, for organisms in which < 30 isolates were recovered
More informationVLLM0421c Medical Microbiology I, practical sessions. Protocol to topic J05
Topic J05: Determination of susceptibility of bacteria to antimicrobial drugs, assessments of resistance factors For study: textbooks, www, keywords e. g. Diffusion disc test ; E-test ; dilution micromethod
More informationMulti-drug resistant microorganisms
Multi-drug resistant microorganisms Arzu TOPELI Director of MICU Hacettepe University Faculty of Medicine, Ankara-Turkey Council Member of WFSICCM Deaths in the US declined by 220 per 100,000 with the
More informationAntibiotics & Resistance
What are antibiotics? Antibiotics & esistance Antibiotics are molecules that stop bacteria from growing or kill them Antibiotics, agents against life - either natural or synthetic chemicals - designed
More informationAntimicrobial susceptibility testing of Campylobacter jejuni and C. coli. CRL Training course in AST Copenhagen, Denmark 23-27th Feb.
Antimicrobial susceptibility testing of Campylobacter jejuni and C. coli CRL Training course in AST Copenhagen, Denmark 23-27th Feb. 2009 Methodologies E-test by AB-biodisk A dilution test based on the
More informationIntroduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018
Introduction to Chemotherapeutic Agents Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018 Antimicrobial Agents Substances that kill bacteria without harming the host.
More informationAntibiotic Susceptibility of Common Bacterial Pathogens in Canine Urinary Tract Infections
Vol.1 No.2 Oct-Dec 2013 ISSN : 2321-6387 Antibiotic Susceptibility of Common Bacterial Pathogens in Canine Urinary Tract Infections S. Yogeshpriya*, Usha N.Pillai, S. Ajithkumar and N. Madhavan Unny Department
More informationSafe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times
Safe Patient Care Keeping our Residents Safe 2016 Use Standard Precautions for ALL Residents at ALL times #safepatientcare Do bugs need drugs? Dr Deirdre O Brien Consultant Microbiologist Mercy University
More informationSheffield User Group Day October Members of the BSAC Working party on Susceptibility Testing present:
Sheffield User Group Day October 2006 Members of the BSAC Working party on Susceptibility Testing present: Trevor Winstanley Jenny Andrews Robin Howe David Livermore (Meeting Chairman) [TW] (Speaker) [JA]
More informationAntimicrobial susceptibility of Salmonella, 2016
susceptibility of Salmonella, 06 Hospital and community laboratories are requested to refer all Salmonella isolated from human salmonellosis cases to ESR for serotyping and the laboratory-based surveillance
More informationR-factor mediated trimethoprim resistance: result of two three-month clinical surveys
Journal of Clinical Pathology, 1978, 31, 850-854 R-factor mediated trimethoprim resistance: result of two three-month clinical surveys S. G. B. AMYES1, A. M. EMMERSON2, AND J. T. SMITH3 From the 'Department
More informationAntimicrobial Susceptibility Testing: Advanced Course
Antimicrobial Susceptibility Testing: Advanced Course Cascade Reporting Cascade Reporting I. Selecting Antimicrobial Agents for Testing and Reporting Selection of the most appropriate antimicrobials to
More informationETX0282, a Novel Oral Agent Against Multidrug-Resistant Enterobacteriaceae
ETX0282, a Novel Oral Agent Against Multidrug-Resistant Enterobacteriaceae Thomas Durand-Réville 02 June 2017 - ASM Microbe 2017 (Session #113) Disclosures Thomas Durand-Réville: Full-time Employee; Self;
More informationJOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH How to cite this article: SHOBHA K L, RAMACHANDRA L, RAO G, MAJUMDER S, RAO S P. EXTENDED SPECTRUM BETA-LACTAMASES (ESBL) IN GRAM NEGATIVE BACILLI AT A TERTIARY
More informationPresence of extended spectrum β-lactamase producing Escherichia coli in
1 2 Presence of extended spectrum β-lactamase producing Escherichia coli in wild geese 3 4 5 A. Garmyn* 1, F. Haesebrouck 1, T. Hellebuyck 1, A. Smet 1, F. Pasmans 1, P. Butaye 2, A. Martel 1 6 7 8 9 10
More informationBurton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents
Burton's Microbiology for the Health Sciences Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents Chapter 9 Outline Introduction Characteristics of an Ideal Antimicrobial Agent How
More informationAntibacterial susceptibility testing
Antibiotics: Antil susceptibility testing are natural chemical substances produced by certain groups of microorganisms (fungi, ) that inhibit the growth of or kill the other that cause infection. Several
More informationMICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC
MICRONAUT Detection of Resistance Mechanisms Innovation with Integrity BMD MIC Automated and Customized Susceptibility Testing For detection of resistance mechanisms and specific resistances of clinical
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXIII NUMBER 1 July 2008 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell, SM (ASCP), Marti Roe SM (ASCP), Ann-Christine Nyquist MD, MSPH Are the bugs winning? The 2007
More informationALARMING RATES OF PREVALENCE OF ESBL PRODUCING E. COLI IN URINARY TRACT INFECTION CASES IN A TERTIARY CARE NEUROSPECIALITY HOSPITAL
ALARMING RATES OF PREVALENCE OF ESBL PRODUCING E. COLI IN URINARY TRACT INFECTION CASES IN A TERTIARY CARE NEUROSPECIALITY HOSPITAL Pearl. A Prabal*,Sourav Maiti Institute of Neurosciences, Kolkata, India
More informationDevelopment of Resistant Bacteria Isolated from Dogs with Otitis Externa or Urinary Tract Infections after Exposure to Enrofloxacin In Vitro
A. M. Brothers, P. S. Gibbs, and R. E. Wooley Development of Resistant Bacteria Isolated from Dogs with Otitis Externa or Urinary Tract Infections after Exposure to Enrofloxacin In Vitro Amy M. Brothers,
More informationBIOLACTAM. Product Description. An innovative in vitro diagnostic for the rapid quantitative determination of ß-lactamase activity
BIOLACTAM www.biolactam.eu An innovative in vitro diagnostic for the rapid quantitative determination of ß-lactamase activity 1.5-3h 20 Copyright 2014 VL-Diagnostics GmbH. All rights reserved. Product
More informationnumber Done by Corrected by Doctor Dr Hamed Al-Zoubi
number 8 Done by Corrected by Doctor Dr Hamed Al-Zoubi 25 10/10/2017 Antibacterial therapy 2 د. حامد الزعبي Dr Hamed Al-Zoubi Antibacterial therapy Figure 2/ Antibiotics target Inhibition of microbial
More informationAntibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting
Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria
More informationReceived 10 November 2006/Returned for modification 9 January 2007/Accepted 17 July 2007
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Oct. 2007, p. 3726 3730 Vol. 51, No. 10 0066-4804/07/$08.00 0 doi:10.1128/aac.01406-06 Copyright 2007, American Society for Microbiology. All Rights Reserved. Comparative
More informationAntibiotic resistance a mechanistic overview Neil Woodford
Antibiotic Resistance a Mechanistic verview BSc PhD FRCPath Consultant Clinical Scientist 1 Polymyxin Colistin Daptomycin Mechanisms of antibiotic action Quinolones Mupirocin Nitrofurans Nitroimidazoles
More informationComparison of antibiotic susceptibility results obtained with Adatab* and disc methods
J Clin Pathol 1984;37:159-165 Comparison of antibiotic susceptibility results obtained with Adatab* and disc methods JJS SNELL, MVS DANVERS, PS GARDNER From the Division of Microbiological Reagents and
More informationAvailable online at ISSN No:
Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2017, 6(4): 36-42 Comparative Evaluation of In-Vitro Doripenem Susceptibility with Other
More information